disulfiram has been researched along with 4-hydroxy-2-nonenal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D | 1 |
| Deshpande, M; Mali, VR; Palaniyandi, SS; Pan, G; Thandavarayan, RA | 1 |
| Palaniyandi, SS; Roy, B | 1 |
1 review(s) available for disulfiram and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels | 2010 |
2 other study(ies) available for disulfiram and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
Impaired ALDH2 activity decreases the mitochondrial respiration in H9C2 cardiomyocytes.
Topics: Aldehyde Dehydrogenase, Mitochondrial; Aldehydes; Animals; Cell Death; Cell Line; Cell Respiration; Disulfiram; DNA Adducts; Mitochondria; Myocytes, Cardiac; Rats | 2016 |
Aldehyde dehydrogenase 2 inhibition potentiates 4-hydroxy-2-nonenal induced decrease in angiogenesis of coronary endothelial cells.
Topics: Aldehyde Dehydrogenase, Mitochondrial; Aldehydes; Animals; Cell Line; Cells, Cultured; Diabetic Cardiomyopathies; Disulfiram; Down-Regulation; Endothelial Cells; Heart; Heart Diseases; Lipid Peroxidation; Mice; Myocardium; Neovascularization, Pathologic; Oncogene Proteins; RNA, Messenger; Sirtuin 1; Transcriptional Regulator ERG; Vascular Endothelial Growth Factor Receptor-2 | 2020 |